A formulation company makes a large order from a supplier that has a WHO-GMP certificate. The batch order passes in-house QC. Then a regulatory audit triggers a series of problems. The supplier had di[...]
Read moreArticles
Our resource center provides company news, thought leadership content, and upcoming virtual events.
17 Min Read
API Import Challenges in Papua New Guinea: 2026 Outlook
Papua New Guinea (PNG) is an Island country situated in the Oceania region. With a population of approximately 11.8 million, this Island comprises 18 provinces with a total area of 462,840 km². T[...]
Read more16 Min Read
Which Essential APIs Are in Chronic Shortage in Fiji’s Healthcare System?
In November 2024, the Fiji Pharmaceutical and Biomedical Services director mentioned that there were medical shortages in many health facilities. This primarily comprises medicines that are used for n[...]
Read more15 Min Read
API Supply Chain Risk Management: Lessons Learned from 2020-2023
If we talk about the years between 2020 to 2023, we are all aware of the changes that come to the global procurement systems and how it impacts the business around the world. In this period, various w[...]
Read more11 Min Read
The 2026 Opportunity Map: Which APIs Will Grow Fastest in Oceania? A Forecast for Pacific Pharma Buyers
Two forces are converging in 2026 that every Pacific Island pharma buyer and Indian API supplier must understand. This is not a coincidence; it is a structural alignment that defines the single cleare[...]
Read more17 Min Read
USFDA & EMA Inspections: How Indian API Plants Maintain Compliance and Win Trust
The USFDA has authorized India to run 703 USFDA-approved pharmaceutical manufacturing facilities, the highest count outside the United States. The country also oversees 386 EU-GMP compliant plants and[...]
Read more20 Min Read
API Market Competition: How Pharma Buyers Can Secure Quality at Competitive Prices
The world for Active Pharmaceutical Ingredient suppliers’ global market has reached a critical inflection point. Competing on price is no longer a competitive advantage; it is now a liability. T[...]
Read more12 Min Read
Why Are Oceania Island Nations Increasingly Switching to Indian APIs?
Pacific Island nations face a sharp paradox. Disease rates are among the highest in the world. Yet, these markets remain overlooked in global pharma supply chains. For years, governments depended on e[...]
Read more12 Min Read
Why Solomon Islands Depends on Indian API Exporters: And How to Enter This Market
Introduction: The Critical Link in Solomon Islands’ Healthcare The Import Reality What would it be for a healthcare business to have a nation where 98% of all medicines are imported? It is the c[...]
Read more24 Min Read
South Pacific API Market Entry: How Indian Pharma Exporters Can Win Fiji, PNG & Beyond
Introduction – The Rising Healthcare Imperative in the Pacific Demand stays steady every year. It does not change with trends or choices. It depends on the basic health needs of people. Indian A[...]
Read more